Otsuka Pharmaceutical Factory

News Release

November 21, 2024: Otsuka Pharmaceutical Factory launches "KIDPAREN Injection," the amino acid, glucose, electrolyte, fat, and multivitamin injection for high calorie parenteral nutrition of patients with chronic kidney disease
November 13, 2024: Otsuka Pharmaceutical Factory and ICU Medical Announce the Establishment of Joint Venture
November 8, 2024: Otsuka Pharmaceutical Factory launches "Tumguide Fiber" with an additional specification of outer diameters of 0.5 mm and 0.75 mm to be used with "Tumguide," a device for checking the position of the nasogastric tube tip
October 29, 2024: Supply of Renewable Energy to Business Partners -Towards Achieving Carbon Neutrality Throughout Our Supply Chain-
September 30, 2024: EN Otsuka Pharmaceutical Co., Ltd. obtains marketing approval of "ENOSOLID Semi Solid for Enteral Use"
September 24, 2024: Otsuka Pharmaceutical Factory obtains marketing approval of "KIDPAREN Injection," the amino acid, glucose, electrolyte, fat, and multivitamin injection for high calorie parenteral nutrition of patients with chronic kidney disease
September 10, 2024: Otsuka Pharmaceutical Factory launches additional OS-1 Jelly Apple Flavor 200 g to the Oral Rehydration Solution OS-1 series

Link